Punjab, Haryana FDA to curb black-marketing against COVID-19 drugs

CHANDIGARH: The Food and Drugs Administration (FDA) Haryana and Punjab government are taking preventive measures to put an end to black marketing and sale of Covid-19 drugs like Remdesivir and Actemra in Delhi from these states.

The drugs are administered to the patients having severe coronavirus sympstoms and are sold in the national capital at higher prices after being purchased in Gurugram. For the purpose of checking black marketinging, both states will now procure these drugs directly from authorized wholesalers only for tertiary care facilities at Covid hospitals.
Narendra Ahooja, state drug controller of FDA Haryana said that, “Out of 4984 active patients, 81 patients are on oxygen and 11 are on ventilators. With these details, a fair assessment can be made for procurement to avoid black marketing.”

Data have been prepared by the State drug authorities for medicines required as per patients admitted in the ICUs and on ventilators to keep a check on hoarding. 100 Remdesivir and 200 Actemra have been procured from CIPLA and have been stocked at a warehouse in Rohtak, according to sources.

LEAVE A REPLY

Please enter your comment!
Please enter your name here